Latest Health News
Healthcare Leaders Highlight 2025 Surprises Including OBBBA and Medicaid Cuts
Healthcare leaders reflect on 2025's major events, including passage of the One, Big, Beautiful Bill Act (OBBBA) with deep Medicaid cuts and AI's rise across sectors. These changes reshaped U.S. healthcare policy amid ongoing sector transformations.
Experts discuss implications for access and innovation.
Northwestern's NU-9 Drug Advances for Alzheimer's and ALS
An experimental drug NU-9, developed at Northwestern University, targets neurodegenerative diseases like Alzheimer's and ALS, now approved for clinical trials. Inventors Richard Silverman and William Klein discuss its potential to address underlying disease mechanisms.
The drug offers hope for multiple conditions beyond initial targets.
New Insights into Anti-Amyloid Alzheimer's Drugs Efficacy
David Gate's team at Northwestern used spatial transcriptomics to study brain responses to anti-amyloid therapies, identifying new molecular targets. This could enhance drug effectiveness beyond slowing disease progression.
Challenges persist with current Alzheimer's treatments targeting amyloid beta.
World's Smallest Pacemaker Invented at Northwestern
John Rogers' team developed a tiny pacemaker, the smallest in the world, through collaboration between engineers and Feinberg investigators. It addresses critical needs for patients requiring such devices.
The innovation highlights bioelectronics advancements.
Cure Hepatitis C Act of 2025 Policy Considerations
The Cure Hepatitis C Act of 2025 raises critical policy and economic questions for addressing the disease. Experts explore design considerations to ensure effective implementation.
This legislation aims to advance hepatitis C elimination efforts.
$50M Texas Funding for Ibogaine Clinical Trials
UTMB Health and UTHealth Houston received $50 million from Texas to lead ibogaine trials for addiction, TBI, and related conditions, involving partners like UT Austin. Ibogaine shows promise based on a 2024 Stanford study for traumatic brain injury in veterans.
The initiative seeks FDA approval to accelerate treatments.
IL-36 Gamma Armored CAR T-Cells Eradicate Solid Tumors
Roswell Park study shows IL-36 gamma 'armored' CAR T-cells boost effectiveness against solid-tumor cancers, leading to eradication in lab models. This advances chimeric antigen receptor T-cell therapy for challenging cancers.
Results outline a new immunotherapy approach.
Massive Study Confirms No Increased Deaths from COVID mRNA Vaccines
A four-year study of 30 million French adults found COVID-19 mRNA vaccines reduced rather than increased death rates. Data supports vaccine safety and efficacy in large populations.
Findings published December 12, 2025.
AI Governance Initiatives Advance Medical Imaging at Mass General Brigham
Mass General Brigham implements AI governance and medical expertise inclusion for tools in stroke detection and cancer screening via imaging. These address the influx of AI technologies efficiently.
Initiatives optimize treatment in oncology and beyond.
Blood Test Improves Prognosis After Cardiac Arrest
A new blood biomarker provides clearer assessment of brain damage post-cardiac arrest, per a large international multicenter study. Led by researchers, it enhances care predictions.
Published around December 12, 2025.
Syntax Bio Funds CRISPR System for Pancreatic Beta Cells
Syntax Bio secured up to $856,250 from Breakthrough T1D for a CRISPR-Cas-driven Cellgorithm to generate pancreatic beta cells. This targets type 1 diabetes treatment innovations.
Weekly CRISPR medicine news from December 12, 2025.
UHC2030 Launches Global Action Tracker on UHC Day 2025
UHC2030 introduced the 'From commitment to action: A global UHC action tracker' on Universal Health Coverage Day 2025. It promotes accountability in health coverage efforts worldwide.
Tracker supports tracking progress toward UHC goals.